Skip to main content

Ironwood Pharmaceuticals, Inc. (IRWD)

NASDAQ: IRWD · IEX Real-Time Price · USD
10.86 -0.30 (-2.69%)
Nov 29, 2021 4:00 PM EST - Market closed

Income Statement (Annual)

Financials in millions USD. Fiscal year is January - December.
Year2020201920182017201620152014201320122011
Revenue
389.52428.41346.64298.28273.96149.5676.4422.88150.2565.87
Revenue Growth
-9.08%23.59%16.21%8.88%83.18%95.66%234.06%-84.77%128.09%-
Cost of Revenue
3.1420.353319.412.2417.6525.587.20.970
Gross Profit
386.39408.07313.64278.87271.72131.9150.8515.68149.2865.87
Selling, General & Admin
140172.45219.68231.18173.28125.25118.33123.2392.5445.92
Research & Development
88.06115.04101.0688.15139.49108.75101.89102.38113.4786.09
Other Operating Expenses
15.380.45174.626.210.980042.0716.030
Operating Expenses
243.45287.95495.36325.54313.75233.99220.22267.68222.04132.01
Operating Income
142.94120.12-181.72-46.67-42.04-102.09-169.37-252-72.76-66.14
Interest Expense / Income
29.4836.637.7236.3739.1531.121.17210.060.06
Other Expense / Income
4.662.0262.9333.890.529.49-0.92-0.19-0.2-1.36
Pretax Income
108.8621.51-282.37-116.94-81.71-142.67-189.62-272.81-72.62-64.85
Income Tax
2.69000000000
Net Income
106.1821.51-282.37-116.94-81.71-142.67-189.62-272.81-72.62-64.85
Net Income Common
106.1821.51-282.37-116.94-81.71-142.67-189.62-272.81-72.62-64.85
Net Income Growth
393.73%---------
Shares Outstanding (Basic)
159156153149145142137116106100
Shares Outstanding (Diluted)
161156153149145142137116106100
Shares Change
2.97%2.22%2.44%2.80%1.95%3.91%18.09%8.88%6.54%-
EPS (Basic)
0.670.14-1.85-0.78-0.56-1.00-1.39-2.35-0.68-0.65
EPS (Diluted)
0.660.14-1.85-0.78-0.56-1.00-1.39-2.35-0.68-0.65
EPS Growth
371.43%---------
Free Cash Flow Per Share
1.050.02-0.46-0.69-0.21-0.78-1.16-2.44-0.79-0.85
Gross Margin
99.19%95.25%90.48%93.49%99.18%88.20%66.53%68.52%99.36%100.00%
Operating Margin
36.70%28.04%-52.42%-15.65%-15.35%-68.26%-221.58%-1101.36%-48.43%-100.41%
Profit Margin
27.26%5.02%-81.46%-39.20%-29.83%-95.40%-248.07%-1192.31%-48.34%-98.45%
Free Cash Flow Margin
42.87%0.89%-20.10%-34.67%-10.92%-74.11%-208.16%-1236.60%-55.64%-128.91%
Effective Tax Rate
2.47%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%-0.00%
EBITDA
141.963.69-232.67-67.91-31.3-99.94-156.12-240.08-61.24-54.79
EBITDA Margin
36.43%14.87%-67.12%-22.77%-11.42%-66.83%-204.25%-1049.26%-40.76%-83.17%
EBIT
138.3458.11-244.64-80.57-42.56-111.57-168.45-251.81-72.57-64.79
EBIT Margin
35.51%13.56%-70.58%-27.01%-15.53%-74.60%-220.38%-1100.52%-48.30%-98.35%
Showing 10 of 15 years
5 more years are available
Start Free Trial
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).